0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Influencing of serum inflammatory factors on IVF/ICSI outcomes among PCOS patients with different BMI

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Overweight and obese are important factors leading to the occurrence of long-term complications in women with polycystic ovary syndrome (PCOS). There has been controversy over whether dissatisfaction with pregnancy outcomes in PCOS patients is influenced by chronic inflammatory status or obesity. This retrospective study analyzed the levels of inflammatory factors in PCOS patients with different body mass index (BMI) groups and effective predictors of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) pregnancy outcomes.

          Methods

          There were 273 women with PCOS diagnosed who completed serum inflammatory factors test between January 2017 and June 2022 were selected. The data of 7,649 infertility PCOS patients who received their first IVF/ICSI treatment in the Reproductive Center of Peking University Third Hospital during the period of the study were collected. Finally, 92 PCOS patients were included in the high BMI group, while 97 patients were included in the normal BMI group. Baseline characteristics were collected and the pregnancy outcomes were compared among the two groups. Then, serum inflammatory factors’ effect on IVF/ICSI pregnancy outcomes were analyzed with age, anti-Mullerian Hormone (AMH) and BMI adjusted.

          Results

          PCOS patients in the high BMI group significantly had a lower number of oocytes retrieved and good quality embryos. The high BMI group PCOS patients had higher levels of IL-6 and lower cumulative clinical pregnancy and live birth rates. The level of GM-CSF was higher in the first cycle transfer and cumulative miscarriage group. High TNF-α was negatively correlated with the first transfer cycle and cumulative clinical pregnancy rates after age, AMH and high BMI adjusted. In addition, the cumulative live birth rate was negatively correlated with high IL-6, but the first cycle transfer and cumulative live birth rates were positively correlated with high IL-1β.

          Discussion

          For PCOS patients, in addition to BMI, attention should also be paid to inflammatory indicators. High levels of TNF-α and IL-6 were negatively correlated with pregnancy outcomes, but high IL-1β was positively correlated with live birth rates among PCOS patients. The level of GM-CSF was higher in miscarriage PCOS patients.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: not found
          • Article: not found

          Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

          (2004)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Inflammation and lipid signaling in the etiology of insulin resistance.

            Inflammation and lipid signaling are intertwined modulators of homeostasis and immunity. In addition to the extensively studied eicosanoids and inositol phospholipids, emerging studies indicate that many other lipid species act to positively and negatively regulate inflammatory responses. Conversely, inflammatory signaling can significantly alter lipid metabolism in the liver, adipose tissue, skeletal muscle, and macrophage in the context of infection, diabetes, and atherosclerosis. Here, we review recent findings related to this interconnected network from the perspective of immunity and metabolic disease. Copyright © 2012 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment.

              To overview the world literature on ovarian hyperstimulation syndrome (OHSS) and modes of prevention and treatment of OHSS. All the pertinent literature on OHSS, its prevention, and strategies for treatment were reviewed. Key to prevention is proper identification of the population at risk, which includes women with either the hormonal or the morphological signs of polycystic ovarian disease, high serum estradiol (E2) before human chorionic gonadotropin (hCG) administration (E2 greater than 4,000 pg/mL), multiple follicular response (greater than 35), younger age, and lean habitus. When a high risk situation is recognized, ovulatory dose of hCG may be reduced, avoided (with cycle cancellation), or substituted by gonadotropin-releasing hormone or its agonist. Luteal support with hCG is to be bypassed. To minimize risk of OHSS, endogenous pregnancy-drived hCG may be eluded by judicious cryopreservation of all embryos. Last, follicular aspiration will allow higher levels of E2 and larger number of follicles to be matured with lesser risk of OHSS than conventional ovulation induction without follicular aspiration. In-house for the severe and intensive care for the critical form. Meticulous fluid and electrolyte balance using both crystalloids and colloids (albumin) until hemoconcentration abates. Paracentesis is indicated for tight ascites, deteriorating kidney functions, and symptomatic relief. Diuretics may be prudently used once hemodilution is achieved. Dopamine drip may be used as a renal rescue, whereas heparin is indicated for thromboembolic phenomena and surgery reserved for abdominal catastrophies. Therapeutic interruption of an early gestation may be lifesaving when all other measures have failed. Although severe and critical OHSS may not be completely avoided, early recognition of high-risk factors, judicious prevention schemes, and treatment strategies should reduce the complication and long-term sequelae of this iatrogenic syndrome.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Endocrinol (Lausanne)
                Front Endocrinol (Lausanne)
                Front. Endocrinol.
                Frontiers in Endocrinology
                Frontiers Media S.A.
                1664-2392
                24 August 2023
                2023
                : 14
                : 1204623
                Affiliations
                [1] 1 Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital , Beijing, China
                [2] 2 National Clinical Research Center for Obstetrics and Gynecology, Peking University Third Hospital , Beijing, China
                [3] 3 Key Laboratory of Assisted Reproduction, Peking University, Ministry of Education , Beijing, China
                [4] 4 Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology , Beijing, China
                Author notes

                Edited by: Johannes Ott, Medical University of Vienna, Austria

                Reviewed by: Bettina Böttcher, Innsbruck Medical University, Austria; Yanqiu Hu, Nanjing Medical University, China

                *Correspondence: Rong Li, roseli001@ 123456sina.com
                Article
                10.3389/fendo.2023.1204623
                10484569
                37693353
                6ae7fa00-bd77-41d5-80ad-51397e30cf3d
                Copyright © 2023 He, Li, Yin, Yang, Wang, Chen, Yang and Qiao

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 12 April 2023
                : 10 August 2023
                Page count
                Figures: 1, Tables: 6, Equations: 0, References: 36, Pages: 9, Words: 5381
                Funding
                This work was supported by the National Science Fund for Distinguished Young Scholars [grant number: 81925013] and Youth Fund of the National Natural Science Foundation of China [grant number: 82101713].
                Categories
                Endocrinology
                Original Research
                Custom metadata
                Reproduction

                Endocrinology & Diabetes
                body mass index,inflammatory factor,polycystic ovary syndrome, in vitro fertilization/intracytoplasmic sperm injection,pregnancy outcomes

                Comments

                Comment on this article